Becton Dickinson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Becton Dickinson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BDX

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. 

CEO
Thomas E. Polen
CEOThomas E. Polen
Employees
74,000
Employees74,000
Headquarters
Franklin Lakes, New Jersey
HeadquartersFranklin Lakes, New Jersey
Founded
1897
Founded1897
Employees
74,000
Employees74,000

BDX Key Statistics

Market cap
55.23B
Market cap55.23B
Price-Earnings ratio
33.11
Price-Earnings ratio33.11
Dividend yield
2.16%
Dividend yield2.16%
Average volume
2.80M
Average volume2.80M
High today
$196.34
High today$196.34
Low today
$189.63
Low today$189.63
Open price
$190.65
Open price$190.65
Volume
3.00M
Volume3.00M
52 Week high
$251.99
52 Week high$251.99
52 Week low
$162.29
52 Week low$162.29

Stock Snapshot

The current Becton Dickinson(BDX) stock price is $192.72, with a market capitalization of 55.23B. The stock trades at a price-to-earnings (P/E) ratio of 33.11 and offers a dividend yield of 2.2%.

On 2025-11-23, Becton Dickinson(BDX) stock moved within a range of $189.63 to $196.34. With shares now at $192.72, the stock is trading +1.6% above its intraday low and -1.8% below the session's peak.

Trading activity shows a volume of 3M, compared to an average daily volume of 2.8M.

The stock's 52-week range extends from a low of $162.29 to a high of $251.99.

The stock's 52-week range extends from a low of $162.29 to a high of $251.99.

BDX News

Simply Wall St 1d
Did New Leadership and Device Launch Just Shift Becton Dickinson’s Healthcare Innovation Trajectory?

BD (Becton, Dickinson and Company) recently appointed Robert Huffines and Jacqueline Wright to its board and unveiled the PureWick™ Portable Collection System,...

Did New Leadership and Device Launch Just Shift Becton Dickinson’s Healthcare Innovation Trajectory?
Simply Wall St 3d
A Look at Becton Dickinson’s Valuation Following New Product Debuts and EMR Integration Momentum

Becton Dickinson (BDX) is making moves on two fronts this month, with the debut of the PureWick Portable Collection System aimed at wheelchair users and the ado...

A Look at Becton Dickinson’s Valuation Following New Product Debuts and EMR Integration Momentum

Analyst ratings

60%

of 15 ratings
Buy
40%
Hold
60%
Sell
0%

People also own

Based on the portfolios of people who own BDX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.